Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
EPS (Diluted)
Yield10 Bioscience Inc
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
EPS (Diluted)
-$1
|
CAGR 3-Years
25%
|
CAGR 5-Years
45%
|
CAGR 10-Years
52%
|
|
Abbvie Inc
NYSE:ABBV
|
EPS (Diluted)
$2
|
CAGR 3-Years
0%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
1%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
EPS (Diluted)
$0
|
CAGR 3-Years
18%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-18%
|
|
Amgen Inc
NASDAQ:AMGN
|
EPS (Diluted)
$12
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
EPS (Diluted)
$13
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
EPS (Diluted)
$34
|
CAGR 3-Years
4%
|
CAGR 5-Years
10%
|
CAGR 10-Years
23%
|
See Also
What is Yield10 Bioscience Inc's EPS (Diluted)?
EPS (Diluted)
-1.8
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's EPS (Diluted) amounts to -1.8 USD.
What is Yield10 Bioscience Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
52%
Over the last year, the EPS (Diluted) growth was 34%. The average annual EPS (Diluted) growth rates for Yield10 Bioscience Inc have been 25% over the past three years , 45% over the past five years , and 52% over the past ten years .